AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32358947 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention evaluations addressing cultural barriers and socio-economic conditions
Number of subjects: 0
Study 32358947 — intervention group
Group type: EXPERIMENTAL
Intervention: Media and peer information sources
Number of subjects: 0
Study 32358947 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural and gender norms
Number of subjects: 0
Study 32358947 — intervention group
Group type: EXPERIMENTAL
Intervention: Education level and socio-economic status
Number of subjects: 0
Study 35438782 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg daily (cohort 1)
Number of subjects: 36
Study 35438782 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg daily + Paclitaxel 80 mg/m2 on days 1, 8, and 15 of each 28-day cycle (cohort 2)
Number of subjects: 36
Study 35438782 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg daily + Paclitaxel 80 mg/m2 (cohort 2)
Number of subjects: 36
Study 32427603 — intervention group
Group type: EXPERIMENTAL
Intervention: Military Sexual Trauma (MST)
Number of subjects: 328
Study 32427603 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger Veterans with MST
Number of subjects: 328
Study 32427603 — intervention group
Group type: COMPARATOR
Intervention: Younger Veterans without MST
Number of subjects: 328
Study 35147758 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold therapy using Siriraj in-house-developed frozen gloves worn during chemotherapy administration.
Number of subjects: 79
Study 35147758 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cold therapy).
Number of subjects: 79
Study 35147758 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold therapy using frozen gloves.
Number of subjects: 79
Study 32925651 — intervention group
Group type: EXPERIMENTAL
Intervention: Nepafenac punctal plug delivery system (N‐PPDS)
Number of subjects: 56
Study 32925651 — intervention group
Group type: COMPARATOR
Intervention: Placebo punctal plug delivery system (p‐PPDS)
Number of subjects: 56
Study 35914101 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 26
Study 35914101 — intervention group
Group type: COMPARATOR
Intervention: Education
Number of subjects: 26
Study 33322448 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 51
Study 33322448 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study 33844393 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose 35 g
Number of subjects: 30
Study 35119463 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System (CDSS) used in intervention clinics
Number of subjects: 18578
Study 35119463 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18578
Study 33754202 — intervention group
Group type: EXPERIMENTAL
Intervention: Nemolizumab 0.125 mg/kg
Number of subjects: 100
Study 33754202 — intervention group
Group type: EXPERIMENTAL
Intervention: Nemolizumab 0.5 mg/kg
Number of subjects: 100
Study 33754202 — intervention group
Group type: EXPERIMENTAL
Intervention: Nemolizumab 2.0 mg/kg
Number of subjects: 100
Study 33754202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33754202 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalfurafine hydrochloride (open-label reference group)
Number of subjects: 100
Study 32054508 — intervention group
Group type: EXPERIMENTAL
Intervention: Septoplasty (surgery to straighten a deviation in the nasal septum) with or without reduction of the inferior nasal turbinate.
Number of subjects: 378
Study 32054508 — intervention group
Group type: COMPARATOR
Intervention: Nasal saline spray followed by a fluorinated steroid spray daily for six months (medical management).
Number of subjects: 378
Study 35380650 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based comprehensive medication reviews including postdischarge follow-up
Number of subjects: 0
Study 35380650 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33271049 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive processing therapy (CPT) for participants with at least 1 significant head injury (HI) during trauma.
Number of subjects: 306
Study 33271049 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive processing therapy (CPT) for participants who denied head injuries but reported serious nonhead injuries (NHI).
Number of subjects: 306
Study 33271049 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive processing therapy (CPT) for participants who denied any injury (NI).
Number of subjects: 306
Study 32845553 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time feedback for self-monitoring via smartphone app for 5 weeks and 13 weeks
Number of subjects: 49
Study 32845553 — intervention group
Group type: COMPARATOR
Intervention: Information about sedentary behavior (control group)
Number of subjects: 49
Study 35387813 — intervention group
Group type: EXPERIMENTAL
Intervention: COPLA with SMT (n=200)
Number of subjects: 400
Study 35387813 — intervention group
Group type: COMPARATOR
Intervention: SMT only (n=200)
Number of subjects: 400
Study 33617937 — intervention group
Group type: EXPERIMENTAL
Intervention: SET2,3
Number of subjects: 575
Study 33617937 — intervention group
Group type: COMPARATOR
Intervention: RCB
Number of subjects: 575
Study 36336088 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg daily
Number of subjects: 42
Study 36336088 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 34530859 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported dietary measures in lifestyle intervention studies
Number of subjects: 380
Study 34530859 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation of treatment effects
Number of subjects: 380
Study 32537688 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO (epoetin-β; mean dose 6000 IU per week)
Number of subjects: 100
Study 32537688 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 100
Study 35548173 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron (100 mg/d)
Number of subjects: 63
Study 35548173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 32331030 — intervention group
Group type: EXPERIMENTAL
Intervention: Deutetrabenazine 12 mg/day, titrating up to a maximum total daily dose of 48 mg/day based on dyskinesia control and tolerability.
Number of subjects: 343
Study 32331030 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in parent studies).
Number of subjects: 343
Study 35354678 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded motor imagery (GMI) along with conventional physiotherapy
Number of subjects: 20
Study 35354678 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (electrotherapy and exercises)
Number of subjects: 20
Study 32278029 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongguan Capsules (TGC) 4.5 g/d for 6 months
Number of subjects: 0
Study 32278029 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment for MI
Number of subjects: 0
Study 35231791 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS)
Number of subjects: 59
Study 35231791 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 59
Study 34605554 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group received information regarding their risk of iron depletion and behaviors to mitigate this risk, including the opportunity to develop an action plan.
Number of subjects: 1533
Study 34605554 — intervention group
Group type: COMPARATOR
Intervention: Control group answered questions regarding awareness of the risk of donation-related iron depletion and actions taken to address iron status.
Number of subjects: 1533
Study 34605554 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with action planning paired with educational information.
Number of subjects: 1533
Study 36117491 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior changing nursing intervention
Number of subjects: 222
Study 36117491 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative nursing management
Number of subjects: 222
Study 33657090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin, DEC, and albendazole (IDA)
Number of subjects: 1919
Study 33657090 — intervention group
Group type: COMPARATOR
Intervention: Diethylcarbamazine citrate and albendazole (DA)
Number of subjects: 1919
Study 32947176 — intervention group
Group type: EXPERIMENTAL
Intervention: Danish school-based road safety educational program using testimonials
Number of subjects: 1007
Study 33825016 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model (Xception) for surgical step classification
Number of subjects: 50
Study 33825016 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model (Xception) for surgical step classification including sub-steps
Number of subjects: 50
Study 32776391 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (CCRT) alone
Number of subjects: 233
Study 32776391 — intervention group
Group type: COMPARATOR
Intervention: Additional chemotherapy to concurrent chemoradiotherapy (CCRT)
Number of subjects: 233
Study 33607459 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental rehearsal
Number of subjects: 62
Study 33607459 — intervention group
Group type: COMPARATOR
Intervention: Control (non-specific rehearsal)
Number of subjects: 62
Study 35512918 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial LAAO patients
Number of subjects: 1904
Study 35512918 — intervention group
Group type: COMPARATOR
Intervention: Warfarin patients
Number of subjects: 1904
Study 33091681 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery-based mentation for neutral stimuli
Number of subjects: 62
Study 33091681 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal-linguistic mentation for worrisome stimuli
Number of subjects: 62
Study 33091681 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial period of suppression for neutral stimuli
Number of subjects: 62
Study 33091681 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppression of worrisome stimuli
Number of subjects: 62
Study 33091681 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery-based mentation for worrisome stimuli
Number of subjects: 62
Study 34915738 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alteplase before thrombectomy (combination treatment)
Number of subjects: 640
Study 34915738 — intervention group
Group type: COMPARATOR
Intervention: Thrombectomy alone (control)
Number of subjects: 640
Study 34915738 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal carotid artery occlusions (subgroup)
Number of subjects: 640
Study 34915738 — intervention group
Group type: EXPERIMENTAL
Intervention: M1 occlusions (subgroup)
Number of subjects: 640
Study 34915738 — intervention group
Group type: EXPERIMENTAL
Intervention: M2 occlusions (subgroup)
Number of subjects: 640
Study 34915738 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridging therapy (combination treatment)
Number of subjects: 640
Study 34915738 — intervention group
Group type: EXPERIMENTAL
Intervention: M2 occlusion (subgroup)
Number of subjects: 640
Study 32109133 — intervention group
Group type: EXPERIMENTAL
Intervention: Hab-o Shefa (n = 41)
Number of subjects: 81
Study 32109133 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 40)
Number of subjects: 81
Study 35897371 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused extracorporeal shockwave therapy (f‐ESWT)
Number of subjects: 42
Study 35897371 — intervention group
Group type: COMPARATOR
Intervention: Radial extracorporeal shockwave therapy (r‐ESWT)
Number of subjects: 42
Study 33482927 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) - one weekly session over 16 weeks and three monthly booster sessions
Number of subjects: 100
Study 33482927 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic Psychotherapy (PDT) - one weekly session over 28 weeks
Number of subjects: 100
Study 32806727 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (ES)
Number of subjects: 26
Study 32806727 — intervention group
Group type: COMPARATOR
Intervention: Passive-recovery control condition (PR)
Number of subjects: 26
Study 35406079 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg‐1)
Number of subjects: 19
Study 35406079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 33604696 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling exercise at 35% of heart rate reserve for 10 minutes after acute mental stress
Number of subjects: 13
Study 33604696 — intervention group
Group type: COMPARATOR
Intervention: Seated rest for 10 minutes after acute mental stress
Number of subjects: 13
Study 32315448 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-performed mechanical plaque control (SPC) at 12-hour intervals
Number of subjects: 42
Study 32315448 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-performed mechanical plaque control (SPC) at 24-hour intervals
Number of subjects: 42
Study 32315448 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-performed mechanical plaque control (SPC) at 48-hour intervals
Number of subjects: 42
Study 35715934 — intervention group
Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil
Number of subjects: 0
Study 35715934 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32826171 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT (Stereotactic Body Radiotherapy)
Number of subjects: 15
Study 32826171 — intervention group
Group type: COMPARATOR
Intervention: HDR-BRT (High-Dose-Rate Brachytherapy)
Number of subjects: 15
Study 34369262 — intervention group
Group type: EXPERIMENTAL
Intervention: motion-based beamformer adaptation
Number of subjects: 22
Study 34369262 — intervention group
Group type: COMPARATOR
Intervention: conventional beamformer adaptation
Number of subjects: 22
Study 33383348 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaliplatin added to preoperative chemoradiotherapy and postoperative chemotherapy, N = 613
Number of subjects: 1236
Study 33383348 — intervention group
Group type: COMPARATOR
Intervention: Preoperative chemoradiotherapy followed by total mesorectal excision and postoperative chemotherapy (standard arm), N = 623
Number of subjects: 1236
Study 33383348 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients experiencing neurotoxic side-effects (grade 1-4)
Number of subjects: 1236
Study 35883921 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive recruitment strategies (community events, school events, recreational centers)
Number of subjects: 362
Study 35883921 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive recruitment strategies (social media advertisements, word of mouth, academic research hub)
Number of subjects: 362
Study 35883921 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive and reactive recruitment methods
Number of subjects: 362
Study 34154588 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 749
Study 34154588 — intervention group
Group type: EXPERIMENTAL
Intervention: CDS
Number of subjects: 749
Study 34154588 — intervention group
Group type: EXPERIMENTAL
Intervention: CDS + SDMT
Number of subjects: 749
Study 35136160 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline global quality of life (gQoL)
Number of subjects: 487
Study 35136160 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional functioning, cognitive functioning, depression, insomnia, body image, future perspective
Number of subjects: 487
Study 35136160 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue
Number of subjects: 487
Study 35136160 — intervention group
Group type: EXPERIMENTAL
Intervention: Social functioning, depression, and fatigue at baseline
Number of subjects: 487
Study 35136160 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional functioning and fatigue at month 12
Number of subjects: 487
Study 35136160 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphical LASSO network analysis
Number of subjects: 487
Study 33853802 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly menu box delivery service including all ingredients and recipes for morning snack, lunch, and afternoon snack, developed by dietitians and meeting menu planning guidelines.
Number of subjects: 8
Study 33853802 — intervention group
Group type: COMPARATOR
Intervention: Access to online menu planning training and a menu assessment tool for cooks.
Number of subjects: 8
Study 35944771 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless bioprosthesis (Perceval)
Number of subjects: 819
Study 35944771 — intervention group
Group type: COMPARATOR
Intervention: Conventional stented bioprosthesis
Number of subjects: 819
Study 33342003 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with testosterone replacement therapy plus alternate-day tadalafil (10 mg)
Number of subjects: 29
Study 33342003 — intervention group
Group type: COMPARATOR
Intervention: Testosterone replacement therapy
Number of subjects: 29
Study 33342003 — intervention group
Group type: COMPARATOR
Intervention: Combination treatment
Number of subjects: 29
Study 35190177 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (N; 3 mg/kg intravenously on days 1, 15, and 29; n=23)
Number of subjects: 44
Study 35190177 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab with Ipilimumab (NI; 1 mg/kg intravenously on day 1; n=21)
Number of subjects: 44
Study 35190177 — intervention group
Group type: COMPARATOR
Intervention: Control group (chemotherapy or previously untreated patients)
Number of subjects: 44
Study 35190177 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall surgical outcomes after neoadjuvant N or NI
Number of subjects: 44
Study 34037436 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term Integrated Amrita Meditation (ST-IAM)
Number of subjects: 30
Study 34037436 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term Integrated Amrita Meditation (LT-IAM)
Number of subjects: 30
Study 34037436 — intervention group
Group type: COMPARATOR
Intervention: Short-term control (ST-control)
Number of subjects: 30
Study 34037436 — intervention group
Group type: COMPARATOR
Intervention: Long-term control (LT-control)
Number of subjects: 30
Study 34250977 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant administration of CYD-TDV and quadrivalent HPV vaccine
Number of subjects: 528
Study 34250977 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential administration of CYD-TDV and quadrivalent HPV vaccine
Number of subjects: 528
Study 36002981 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot balloon finger palpation for cuff pressure control
Number of subjects: 168
Study 36002981 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent cuff pressure control
Number of subjects: 168
Study 36002981 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cuff pressure control
Number of subjects: 168
Study 36002981 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 168
Study 36002981 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 168
Study 33884504 — intervention group
Group type: EXPERIMENTAL
Intervention: PACO/NP
Number of subjects: 40
Study 33884504 — intervention group
Group type: EXPERIMENTAL
Intervention: PACO/PAS
Number of subjects: 40
Study 33884504 — intervention group
Group type: EXPERIMENTAL
Intervention: PLA/NP
Number of subjects: 40
Study 33884504 — intervention group
Group type: COMPARATOR
Intervention: PLA/PAS
Number of subjects: 40
Study 36102519 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise therapy
Number of subjects: 43
Study 616739365 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonidegib 200 mg daily
Number of subjects: 230
Study 616739365 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonidegib 800 mg daily
Number of subjects: 230
Study 35313512 — intervention group
Group type: EXPERIMENTAL
Intervention: exercise+nutrition group
Number of subjects: 26
Study 35313512 — intervention group
Group type: COMPARATOR
Intervention: exercise group
Number of subjects: 26
Study 33751845 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced diet
Number of subjects: 122
Study 33751845 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-reduced diet
Number of subjects: 122
Study 33751845 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined sample (both diets)
Number of subjects: 122
Study 32107364 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose EC-MPS plus low-dose MZR
Number of subjects: 115
Study 32107364 — intervention group
Group type: COMPARATOR
Intervention: Low-dose EC-MPS
Number of subjects: 115
Study 32107364 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose MZR
Number of subjects: 115
Study 35356618 — intervention group
Group type: EXPERIMENTAL
Intervention: Dignity therapy (4 weeks intervention)
Number of subjects: 120
Study 36321877 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium-disilicate crowns
Number of subjects: 60
Study 36321877 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia crowns
Number of subjects: 60
Study 36321877 — intervention group
Group type: COMPARATOR
Intervention: Both materials
Number of subjects: 60
Study 36321877 — intervention group
Group type: COMPARATOR
Intervention: Implants
Number of subjects: 60
Study 36321877 — intervention group
Group type: COMPARATOR
Intervention: Adjacent teeth
Number of subjects: 60
Study 32379201 — intervention group
Group type: COMPARATOR
Intervention: Maternal influenza immunization
Number of subjects: 0
Study 32379201 — intervention group
Group type: COMPARATOR
Intervention: Meningococcal conjugate vaccine
Number of subjects: 0
Study 34151820 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracolumbar manipulation and diaphragmatic release techniques
Number of subjects: 30
Study 34151820 — intervention group
Group type: COMPARATOR
Intervention: Sham group (no active treatment)
Number of subjects: 30
Study 33504190 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran (150/110 mg BID)
Number of subjects: 5388
Study 33504190 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (100 mg QD)
Number of subjects: 5388
Study 33504190 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of anticoagulant therapy
Number of subjects: 5388
Study 35791845 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% supramolecular salicylic acid combined with ultra‐pulsed CO2 fractional laser
Number of subjects: 20